| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJMED.2011.01.018 |
| P698 | PubMed publication ID | 21592450 |
| P50 | author | Martin O'Donnell | Q37392962 |
| John W. Eikelboom | Q42846212 | ||
| P2093 | author name string | Jack Hirsh | |
| Magdalena Sobieraj-Teague | |||
| Nina Raju | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| aspirin | Q18216 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 621-629 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease | |
| P478 | volume | 124 |
| Q33622632 | A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease. |
| Q51747428 | A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. |
| Q26864015 | A systematic review of aspirin in primary prevention: is it time for a new approach? |
| Q92405782 | All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study |
| Q54637252 | An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds. |
| Q35752619 | Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q35752591 | Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q36015163 | Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries? |
| Q90331296 | Aspirin and diabetes mellitus in primary prevention: the Endless Conundrum |
| Q38036541 | Aspirin as adjuvant therapy for colorectal cancer--reinterpreting paradigms |
| Q41511350 | Aspirin for Prevention of Cardiovascular Disease |
| Q26774150 | Aspirin for primary prevention of cardiovascular disease |
| Q38047265 | Aspirin for primary prevention of cardiovascular disease events |
| Q43123151 | Aspirin for primary prevention: a challenging decision |
| Q62072511 | Aspirin for the primary prevention of cardiovascular diseases |
| Q88190239 | Aspirin in heart failure: don't throw the baby (aspirin) out with the bathwater |
| Q21132402 | Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials |
| Q37331767 | Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease |
| Q36606633 | Association between use of specialty dietary supplements and C-reactive protein concentrations. |
| Q42939653 | Community-based interventions to improve outcomes for cardiovascular disease [letter]. |
| Q36082805 | Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews |
| Q48237396 | Economic evaluation of genetic screening for Lynch syndrome in Germany. |
| Q57256594 | Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly |
| Q37231429 | Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men |
| Q34233473 | Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation |
| Q28071501 | Effects of Aspirin on Endothelial Function and Hypertension |
| Q44197079 | Evaluation of a systematic cardiovascular disease risk reduction strategy in primary healthcare: an exploratory study from Zhejiang, China |
| Q91840942 | Factors Influencing Aspirin Hyporesponsiveness in Elderly Chinese Patients |
| Q91972114 | Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis |
| Q37251490 | Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association |
| Q35028969 | How confidence intervals become confusion intervals |
| Q38114868 | Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither? |
| Q40059650 | Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration. |
| Q36836426 | Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey |
| Q37378488 | Positive influence of aspirin on coronary endothelial function: Importance of the dose |
| Q89515566 | Prevention of stroke in people living with HIV |
| Q35752598 | Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
| Q38271121 | Prophylactic use of aspirin: systematic review of harms and approaches to mitigation in the general population. |
| Q39028044 | Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin |
| Q89456574 | Review of the top 5 cardiology studies of 2017-18 |
| Q34376832 | Role of aspirin in cancer prevention |
| Q42756740 | Should aspirin be used for the primary prevention of cardiovascular disease in the general population? |
| Q38201583 | Suitability of antiplatelet therapy in hypertensive patients. |
| Q34576281 | Systematic reviews and meta-analyses for more profitable strategies in peripheral artery disease |
| Q90427348 | The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis |
| Q37707869 | The impact of antiplatelet medication on hand and wrist surgery. |
| Q91589497 | The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy |
| Q28546905 | Use of medications and lifestyles of hypertensive patients with high risk of cardiovascular disease in rural China |
| Q84213269 | Why meta-analyses on the same topic lead to different conclusions? |
| Q88983094 | Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018 |
Search more.